Abbvie Overview
Abbvie Target Price
Analysts' average 12-month price target for Abbvie is $290.
Get informed when a big investor buys or sells
+ FollowShare Price
$294.9
Average Target Price
$294.00
0.3% downside
0.3% downside21 analysts in the last 4 months
High: $325 | Low: $260
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-23 | Goldman Sachs | $294 | 0.3% downside |  |
| 2026-10-21 | Barclays | $325 |  10.2% upside | |
| 2026-10-08 | Cantor FitzgeraldCarter Gould | $290 | 1.7% downside | |
| 2026-10-07 | Morgan Stanley | $310 | 5.1% upside | |
| 2026-10-06 | ScotiabankLouise Chen | $320 | 8.5% upside | |
| 2026-09-10 | HSBCRajesh Kumar | $315 | 6.8% upside | |
| 2026-08-20 | Piper Sandler | $303 | 2.7% upside | |
| 2026-08-17 | Wells Fargo | $300 | 1.7% upside | |
| 2026-08-13 | Wolfe ResearchAlexandria Hammond | $300 | 1.7% upside | |
| 2026-08-04 | Guggenheim | $288 | 2.3% downside | |
| 2026-08-03 | Morgan Stanley | $296 | 0.4% upside | |
| 2026-08-03 | Canaccord GenuityGary Nachman | $290 | 1.7% downside | |
| 2026-07-29 | Barclays | $300 | 1.7% upside | |
| 2026-07-22 | Canaccord Genuity | $282 | 4.4% downside | |
| 2026-07-13 | UBS | $260 | 11.8% downside | |
| 2026-07-13 | BMO Capital | $300 | 1.7% upside | |
| 2026-07-10 | RBC CapitalTrung Huynh | $280 | 5.1% downside | |
| 2026-07-10 | Wells Fargo | $295 | 0% upside | |
| 2026-07-09 | Guggenheim | $261 | 11.5% downside | |
| 2026-07-06 | HSBC | $300 | 1.7% upside | |
| 2026-07-06 | Cantor Fitzgerald | $265 | 10.1% downside | |
| 2026-06-23 | Canaccord Genuity | $273 | 7.4% downside | |
| 2026-06-22 | Wells Fargo | $260 | 11.8% downside | |
| 2026-05-15 | Evercore ISI | $235 | 20.3% downside | |
| 2026-05-14 | Piper Sandler | $298 | 1.1% upside | |
| 2026-04-30 | Morgan Stanley | $278 | 5.7% downside | |
| 2026-04-23 | Piper Sandler | $294 | 0.3% downside | |
| 2026-04-20 | Canaccord Genuity | $262 | 11.2% downside | |
| 2026-04-10 | GuggenheimVamil Divan | $249 | 15.6% downside | |
| 2026-04-08 | Cantor Fitzgerald | $240 | 18.6% downside | |
| 2026-02-24 | RBC CapitalTrung Huynh | $260 | 11.8% downside | |
| 2026-02-19 | Barclays | $275 | 6.7% downside | |
| 2026-02-18 | Piper Sandler | $299 | 1.4% upside | |
| 2026-02-05 | UBS | $230 | 22% downside | |
| 2026-02-04 | Evercore ISIGavin Clark-Gartner | $228 | 22.7% downside | |
| 2026-01-28 | Goldman SachsAsad Haider | $223 | 24.4% downside | |
| 2026-01-20 | Berenberg Bank | $275 | 6.7% downside | |
| 2026-01-15 | BMO CapitalEvan David Seigerman | $258 | 12.5% downside | |
| 2026-01-07 | UBS | $240 | 18.6% downside | |
| 2025-12-12 | Morgan Stanley | $269 | 8.8% downside | |
| 2025-12-10 | HSBC | $265 | 10.1% downside | |
| 2025-11-05 | Piper SandlerDavid Amsellem | $289 | 2% downside | |
| 2025-11-03 | Raymond JamesGary Nachman | $256 | 13.2% downside | |
| 2025-10-20 | Guggenheim | $242 | 17.9% downside | |
| 2025-10-17 | Raymond JamesGary Nachman | $250 | 15.2% downside | |
| 2025-10-10 | Piper Sandler | $284 | 3.7% downside | |
| 2025-10-09 | Cantor Fitzgerald | $250 | 15.2% downside | |
| 2025-10-03 | UBS | $251 | 14.9% downside | |
| 2025-10-02 | HSBC | $225 | 23.7% downside | |
| 2025-09-15 | Cantor FitzgeraldCarter Gould | $245 | 16.9% downside | |